Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-019602

Chief Commercial Officer bought 5,000 shares at $6.85 ($34,259)

From the SEC's structured data for this filing

Trades in this filing

Millian Craig Stuart · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-03-14 Purchase : show line 1 in the form +5,000 $6.85 $34,259 5,000 D
Open-market purchases · 5,000 sh · avg $6.85 · $34,259
Loading xslF345X03/doc4.xml…